D'Angelo, S. P., Shoushtari, A. N., Keohan, M. L., Dickson, M. A., Gounder, M. M., Chi, P., . . . Tap, W. D. (2016). Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab. Clin Cancer Res.
Citação norma ChicagoD'Angelo, Sandra P., et al. "Combined KIT and CTLA-4 Blockade in Patients With Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib Plus Ipilimumab." Clin Cancer Res 2016.
MLA引文D'Angelo, Sandra P., et al. "Combined KIT and CTLA-4 Blockade in Patients With Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib Plus Ipilimumab." Clin Cancer Res 2016.
警告：這些引文格式不一定是100％准確.